ALZHEIMER : SCIENCE 
NEWS: Alzeihmer’s new blood Test
 
WHAT’S IN THE NEWS?
Researchers have developed a new blood test to
detect Alzheimer’s disease that helps diagnose the disease even at the early
stage of mild cognitive impairment.
 
PrecivityAD2 Blood Test for Alzheimer's Disease
Overview
 - Research
     Institution: Lund University, Sweden
 
 - Accuracy:
     About 90% in identifying Alzheimer's Disease (AD) in individuals with
     cognitive symptoms
 
 - Publication:
     "Blood Biomarkers to Detect Alzheimer Disease in Primary Care and
     Secondary Care" by Sebastian Palmqvist et al, JAMA, July 28
 
 
Alzheimer's Disease (AD)
 - A
     serious brain disorder affecting mainly older individuals
 
 - Leads
     to memory loss and cognitive impairment
 
 - Traditional
     diagnosis involves expensive PET scans
 
 
PrecivityAD2 Blood Test
 - Function:
     Detects Alzheimer's by measuring specific proteins in blood
 
 - Key
     Proteins:
 
 
  - Plasma
      Phosphorylated-Tau217 (p-tau217): Linked to
      neurofibrillary tangles
 
  - Amyloid-Beta
      (AB42 and AB40): Associated with brain plaques
 
 
 
Key Findings
 - PrecivityAD2
     is effective in detecting early-stage Alzheimer's
 
 - Easier,
     less invasive, and more affordable than PET scans
 
 
Importance
 - Ease
     of Use: Simple blood sample needed
 
 - Cost-Effective:
     More affordable than traditional methods
 
 - Early
     Detection: Facilitates early treatment and
     management
 
 
Expert Views
 - Howard
     Fillit (Alzheimer’s Drug Discovery Foundation) suggests it could replace
     PET scans as the primary diagnostic tool
 
 
Impact on India
 - Growing
     Elderly Population: Rising Alzheimer's cases
 
 - Benefits:
     Cost-effective, easy diagnostic method
 
 - Requirements:
     Training and preparation for doctors
 
 
Benefits of Early Detection
 - Earlier
     Treatment: May slow disease progression
 
 - Better
     Planning: Ensures support for patients and
     families
 
 - Clinical
     Trials: Enables participation in new
     treatment trials
 
 Conclusion
 - PrecivityAD2
     is a significant advancement in Alzheimer's diagnosis, promising better
     and earlier treatment globally, including in India.
 
 Source
: https://www.thehindu.com/sci-tech/health/what-is-the-new-alzheimers-blood-test/article68482512.ece#:~:text=Scientists%20at%20Lund%20University%20in,in%20people%20experiencing%20cognitive%20symptoms.